To Be or Not to Be Treated: That Is the Question in Managing a Fetus With Cardiac Injury Exposed to Anti‐SSA/Ro
Main Authors: | Jill Buyon, Amit Saxena, Deborah Friedman, Peter Izmirly |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.122.025580 |
Similar Items
-
Contribution of S100A4-expressing fibroblasts to anti-SSA/Ro-associated atrioventricular nodal calcification and soluble S100A4 as a biomarker of clinical severity
by: Christina E. M. Firl, et al.
Published: (2023-04-01) -
Neuromyelitis optic with positive Anti-AQP4 and Anti-SSA/Ro antibody
by: Riwanti Estiasari, et al.
Published: (2019-03-01) -
Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies
by: P. Airò, et al.
Published: (2011-09-01) -
Possible role of anti-SSA/Ro antibodies in the pathogenesis of pulmonary hypertension
by: Kelsey Guerreso, et al.
Published: (2016-01-01) -
Isolated anti-Ro/SSA thrombocytopenia: a rare feature of neonatal lupus
by: Imene Dahmane Ayadi, et al.
Published: (2015-11-01)